GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ca Inc. (CA) [hlAlert]

Rating:
Underperform
CA
down 15.22 %

Ca Inc. (CA) rated Underperform by Bernstein

Posted on: Tuesday,  Nov 6, 2012  9:25 AM ET by Bernstein

Bernstein rated Underperform Ca Inc. (NASDAQ: CA) on 11/06/2012, when the stock price was $23.00. Since
then, Ca Inc. has gained 17.96% as of 01/22/2016's recent price of $27.13.
If you would have followed this Bernstein's recommendation on CA, you would have lost 15.22% of your investment in 1172 days.

Careside has developed and plans to sell a proprietary blood testing systemcalled the Careside system. It is designed to decentralize laboratoryoperations. The system consists of a testing instrument called the CareSideAnalyzer and disposable test cartridges. It performs blood tests in the same location as the patient, or what is commonly called point-of-care testing. The company's goal is to make decentralized testing with the Careside system the standard for routine and critical care blood testing.

A central advantage for Bernstein clients is the ability to harness our highly regarded expertise in investment research and management. Originally known as a value investor, Bernstein has long been known for seeking out stocks with temporarily depressed prices due to unwarranted short-term pessimism about a company’s ability to recover from its current problems. This philosophy is embodied in our flagship Strategic Value portfolio. But since value and growth stocks have alternated leadership—with no clear signal of when one style will give way to the other—we’ve developed a Strategic Growth portfolio that seeks out leading companies whose stock prices don’t fully reflect their companies’ potential for superior earnings growth.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/6/2012 9:25 AM Sell
None
23.00
as of 12/31/2012
1 Week up  1.61 %
1 Month up  0.81 %
3 Months up  4.43 %
1 YTD up  4.43 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy